Cambridge history professor William O’Reilly published a 2018 journal article that copied large sections (roughly half the pages) almost verbatim from two essays by one of his own undergraduate students.
A university tribunal upheld the plagiarism complaint but ruled it “negligent” rather than deliberate. He kept his job and is still listed as Associate Professor.
Further uncredited overlaps in earlier papers were later flagged on PubPeer.
Compare the sustained media coverage and pressure that surrounded Jason Arday.
Why the difference in intensity and outcome?
Here’s Kathleen Stock laughing and mocking Cambridge professor Jason Arday a few days ago. This is one of the videos she’s just hurriedly deleted. Privileged, academic ivory tower snobbiness and nastiness - with an undertone of you know what. #Terfs#GenderCritical
It is possible to get to the right iliac bifur via a retroperitoneal incision. It’s often said a counter incision is required/femoral anastomosis. With appropriate setup it can be accomplished. The anastomosis is difficult for the surgeon(trainee) but easier for patient recovery
Data Drop: 5-Year Outcomes with the TREO® Abdominal Stent-Graft System.
In the U.S. IDE pivotal study, the TREO® system demonstrated exceptional long-term performance:
150 patients across 29 U.S. centers
✅ 0% aneurysm-related mortality, ruptures, or open conversions (0/150)
✅ Low endoleak rates — Type I: 3.3%, (5/150) Type III: 0% (0/150)
✅ High rate of sac regression at 5 years 61.4% (43/70)
✅ Minimal device migration 0.7% (1/150)
✅ Low secondary interventions through 5 years 10.7% (16/150)
Backed by independent core laboratory review , these results confirm TREO®’s clinical durability and long-term safety.
Terumo Aortic is proud to offer TREO® —Versatile by design. Fit for any anatomy.*
*Per IFU
📖 Full study: https://t.co/P8IRfktktf
Call for Volunteers -Vascular Mission to PortSudan
The Sudanese Association of Vascular Surgeons (SudAVaS) is proud to announce our upcoming mission to Port Sudan, taking place from 16th - 23rd January 2026.
Update from the @VascularSVS on managing intermittent claudication:
🚶Supervised walking = 1st-line therapy; home-based if unfeasible
💊Rivaroxaban + ASA for PAD/IC with high-risk comorbidities & post-revasc (low risk 🩸)
🙌Shared-decision making for revasc options
⬇️link below
Demonstration of parachute technique for the carotid LSA bypass. Everything is clearly able to be seen. Half the anastomosis by the fellow in 1 minute. #AortaEd keep tension on everything graft and suture to clearly visualize the artery. No need to even grab it
🤖 MULTIPLATFORM MASTERY with Mr @benchallacombe!
UK's current robotic landscape expanding rapidly:
🇬🇧 ESTABLISHED & NEW:
• CMR Versius
• Medtronic HUGO
• Intuitive Da Vinci (Single Port, X/Xi)
• Dexter Swiss (hybrid lap/robot)
• Aquablation Procept
🌟 EMERGING:
• Toumai Microport
• Edge Medical
• Shurui, Kang Duo/Sagebot
• SS Mantra
💡 Ben's multiplatform wisdom:
"Same operation, different robot. Same principles, different feel. Need to ENTHUSE your team!"
The future is #multiplatform! 🚀